Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 295 of 6351
-
Can mindfulness ease pain and protect aging minds?
Symptom relief Not yet recruitingThe goal of this clinical trial is to pilot a randomized controlled trial comparing an adaptation of mindfulness-based cognitive therapy to the health enhancement program for chronic pain and early cognitive decline. The main questions it aims to answer in a later fully powered r…
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
Can a targeted drug boost stem cell transplants for leukemia?
Disease control Not yet recruitingThis phase II MyeloMATCH treatment trial compares the effect of adding venetoclax or placebo to reduced intensity conditioning chemotherapy with fludarabine and busulfan or melphalan, with or without total body irradiation, followed by hematopoietic stem cell transplant and eithe…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 02:00 UTC
-
New combo therapy aims to stop prostate cancer spread in high-risk patients
Disease control Recruiting nowThe advent of PSMA-PET has improved sensitivity and specificity in staging prostate cancer, particularly in intermediate- and high-risk disease. This has created uncertainty in the management of patients with PSMA-positive but conventionally negative pelvic lymphadenopathy (i.e.,…
Phase 2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New Drug-Free neck therapy shows promise for preeclampsia
Symptom relief Recruiting nowPreeclampsia is one of the most common and serious complications of pregnancy, affecting both the mother and baby. It is a condition characterized by high blood pressure and can lead to severe complications, including neurological issues and reduced blood flow to the placenta. Pr…
Sponsor: Fundación Internacional René Mey • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New daily pill could shield kids from TB
Prevention Not yet recruitingThis study aims to find the proposed dose of Rifapentine (RPT) taken once daily with Isoniazid (INH) for 28 days to prevent tuberculosis (TB). The study will take place at multiple locations and children under 13 years old will be divided into two groups: one group will include c…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
Double probe heat therapy could slash cervical cancer risk in HIV-Positive women
Prevention Not yet recruitingCervical cancer disproportionately affects women in low- and middle-income countries (LMICs), particularly women living with HIV (WLWH) who have a 6-fold increased risk of cervical cancer compared to women in the general population. Thermal ablation (TA) is recommended by the Wor…
Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
New combo therapy targets hard-to-treat lung cancer mutation
Disease control Not yet recruitingThis phase II trial tests how well giving CIMAvax-EGF with KRAS G12C inhibitor (sotorasib or adagrasib) for the treatment of patients with KRAS G12C mutated non small cell lung cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts…
Phase 2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Real-World data may reveal Pluvicto's true impact on advanced prostate cancer survival
Disease control Not yet recruitingThis study aims to evaluate the various aspects of treatment effectiveness of \[177Lu\]Lu-PSMA-617 (Pluvicto) in mCRPC patients in both pre- and post-taxane settings. The study will be conducted using real-world data sources from the United States (US) and Germany.
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can a new antibiotic combo beat Drug-Resistant urinary infections in the blood?
Disease control Not yet recruitingThis study is designed to better understand how well a new antibiotic combination, cefepime/enmetazobactam (FEP/META), works in patients with complicated urinary tract infections that have spread to the bloodstream (bacteremia). These infections are caused by bacteria that are re…
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a new drug heal stomach ulcers faster?
Disease control Not yet recruitingA Multinational, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group, Phase 3 Study to Evaluate the Efficacy and Safety of DWP14012 in Participants with Gastric Ulcer
Phase 3 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Could a single device make emergency intubation faster and safer?
Knowledge-focused Not yet recruitingEndotracheal intubation is a critical airway management procedure that frequently requires adjunctive devices, such as stylets or elastic bougies, to facilitate successful tube placement. Although videolaryngoscopy has become increasingly common, access to videolaryngoscopes rema…
Sponsor: Huseyin Cahit Halhalli, MD • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Can a new pill change the Brain's activity in early Alzheimer's?
Disease control Not yet recruitingThe primary purpose of this study is to evaluate proof of mechanism (POM) and long-term safety and tolerability of E2511 in participants with Early AD. The study consists of 2 parts. In Part A, participants will be randomly assigned to receive either E2511 or donepezil. In Part B…
Phase 1 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can acupuncture shorten induced labor and ease pain?
Symptom relief Not yet recruitingIn France, labor induction rate is above 25.8%. Labor induction with Cook's balloon is a non-hormonal mechanical method. At Roubaix's maternity, midewifes can adminitred acupuncture therapy to help to manage this labor induction. No studies where found about an effect of acupun…
Sponsor: Centre Hospitalier de Roubaix • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Can a new biologic slow kidney damage in IgA nephropathy?
Disease control Not yet recruitingThe study will assess how ARGX-121 affects immunoglobulin A nephropathy (IgAN) disease outcomes, such as renal function, how it is distributed and eliminated from the body, and how the immune system responds in adults with IgAN. While in the study, participants will continue to …
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Could organs from HIV-Positive donors be safe for recipients with HIV?
Disease control Recruiting nowThis is a prospective, multicenter clinical study. The objective is to determine whether a liver transplant from a deceased donor with HIV is associated with an increased risk of opportunistic infection and cancer. Adults with Human Immunodeficiency Virus (HIV) in need of a liver…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Could pesticides fuel brain tumor aggression?
Knowledge-focused Not yet recruitingThis prospective, interventional, monocentric study will aim at investigating the relationship between pesticide exposure and the treatment response of patients with GBM. The study will be conducted on a population of 120 participants aged over 18 years, diagnosed with IDH wild-…
Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
A phone game takes on menopause brain fog
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate the effect of a mobile game-based cognitive intervention on brain fog and psychological well-being in menopausal women aged 45-55 years. The main questions it aims to answer are: Are Brain Fog Scale scores lower among women in the m…
Sponsor: Medipol University • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Genetic test may flag type 1 diabetes risk years before symptoms
Knowledge-focused Not yet recruitingThis study is a test to find out if genetic information can be used to help healthcare providers identify diseases. Specifically, the investigators want to find out how genetic information can help healthcare providers identify people who may benefit from early screening for type…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
AI coaching may help ostomy patients sleep better
Symptom relief Not yet recruitingIndividuals living with an intestinal or urinary stoma frequently report disturbed sleep. Night-time pouch filling and leakage, odour and gas concerns, restricted sleeping positions, peristomal skin problems and the need for night-time pouch emptying interrupt sleep, while anxiet…
Sponsor: Koç University • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Heated chemo offers new hope for bladder cancer patients facing surgery
Disease control Not yet recruitingThis is a Phase II, prospective, single-arm, open-label clinical study evaluating hyperthermic intravesical chemotherapy (HIVEC) with Mitomycin C in patients with high-grade, non-muscle-invasive bladder cancer (NMIBC) who are BCG-non-responsive or BCG-intolerant and are ineligibl…
Sponsor: AC.TA. S.r.l. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC